BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 33719004)

  • 1. Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.
    Liu X; Liu S; Tang Y; Pu Z; Xiao H; Gao J; Yin Q; Jia Y; Bai Q
    Neurochem Res; 2021 Jun; 46(6):1514-1539. PubMed ID: 33719004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
    Qiao CM; Sun MF; Jia XB; Li Y; Zhang BP; Zhao LP; Shi Y; Zhou ZL; Zhu YL; Cui C; Shen YQ
    Neurochem Res; 2020 Sep; 45(9):2128-2142. PubMed ID: 32556930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein Reactivates Dopaminergic Nerve Injury and Intestinal Inflammation with Disturbing Intestinal Microflora and Fecal Metabolites in a Convalescent Parkinson's Disease Mouse Model.
    Pu Z; Liu S; Guo Z; Zhang X; Yan J; Tang Y; Xiao H; Gao J; Li Y; Bai Q
    Neuroscience; 2023 Aug; 524():120-136. PubMed ID: 37321369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota disorders in PD mice.
    Xie W; Gao J; Jiang R; Liu X; Lai F; Tang Y; Xiao H; Jia Y; Bai Q
    Neurotoxicology; 2020 Jan; 76():200-212. PubMed ID: 31790727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson's disease mouse models.
    Zhang F; Pan L; Lian C; Xu Z; Chen H; Lai W; Liang X; Liu Q; Wu H; Wang Y; Zhang P; Zhang G; Liu Z
    Brain Res Bull; 2024 Aug; 214():110989. PubMed ID: 38825252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
    Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
    Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
    Pariyar R; Bastola T; Lee DH; Seo J
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
    Zhang J; Sun B; Yang J; Chen Z; Li Z; Zhang N; Li H; Shen L
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise training has a protective effect in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model with improved neural and intestinal pathology and modified intestinal flora.
    Wang Y; Pu Z; Zhang Y; Du Z; Guo Z; Bai Q
    Behav Brain Res; 2023 Feb; 439():114240. PubMed ID: 36455673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
    Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
    Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
    Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
    J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Price DA; Martinez AA; Seillier A; Koek W; Acosta Y; Fernandez E; Strong R; Lutz B; Marsicano G; Roberts JL; Giuffrida A
    Eur J Neurosci; 2009 Jun; 29(11):2177-86. PubMed ID: 19490092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
    Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
    Hong J; Sha S; Zhou L; Wang C; Yin J; Chen L
    Cell Death Dis; 2015 Jul; 6(7):e1832. PubMed ID: 26203861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson's disease mice by gut microbiome.
    Shan J; Qu Y; Wang S; Wei Y; Chang L; Ma L; Hashimoto K
    Brain Res Bull; 2021 Dec; 177():103-110. PubMed ID: 34560239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.
    Zhang Y; Qin L; Xie J; Li J; Wang C
    Life Sci; 2020 Jul; 253():117745. PubMed ID: 32376269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT4 Receptor is Protective for MPTP-induced Parkinson's Disease Mice Via Altering Gastrointestinal Motility or Gut Microbiota.
    Cui C; Shi Y; Hong H; Zhou Y; Qiao C; Zhao L; Jia X; Zhao W; Shen Y
    J Neuroimmune Pharmacol; 2023 Dec; 18(4):610-627. PubMed ID: 37782386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
    Xu Z; Lian C; Pan L; Lai W; Zhang F; Peng L; Zhou S; Zhao G; Yang X; Zhang G; Tan Z; Wang Y
    Brain Res Bull; 2023 Oct; 202():110729. PubMed ID: 37579888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.